Publication | Closed Access

Adenovirus-mediated anti-sense ERK2 gene therapy inhibits tubular epithelial–mesenchymal transition and ameliorates renal allograft fibrosis

Gene TherapiesFibrosisTransplantationTranslational MedicineKidney TransplantImmunologyRenal InflammationPathologyCell BiologyRenal Allograft FibrosisKidney Tubule RemodelingMedicineCell TransplantationCell SignalingTubular Epithelial–mesenchymal TransitionKidney Research